<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ACritical_illness_cover</id>
	<title>Definition:Critical illness cover - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ACritical_illness_cover"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Critical_illness_cover&amp;action=history"/>
	<updated>2026-06-14T06:37:49Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Critical_illness_cover&amp;diff=16931&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Critical_illness_cover&amp;diff=16931&amp;oldid=prev"/>
		<updated>2026-03-15T08:27:13Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏥 &amp;#039;&amp;#039;&amp;#039;Critical illness cover&amp;#039;&amp;#039;&amp;#039; is a [[Definition:Life insurance | life]] and [[Definition:Health insurance | health]] insurance product that pays a lump-sum benefit upon the policyholder&amp;#039;s diagnosis of a specified serious medical condition, such as cancer, heart attack, stroke, or organ failure. Unlike indemnity-based [[Definition:Medical expense insurance | medical expense insurance]], which reimburses actual treatment costs, critical illness cover delivers a fixed amount irrespective of the medical bills incurred, giving the insured broad discretion over how the funds are used — whether for treatment, mortgage payments, or living expenses during recovery. The product originated in South Africa in the 1980s, conceived by cardiac surgeon Marius Barnard, and has since become a significant line of business across the United Kingdom, Asia-Pacific markets — particularly in Hong Kong, Singapore, Malaysia, and mainland China — and parts of Europe.&lt;br /&gt;
&lt;br /&gt;
⚙️ Policyholders select a [[Definition:Sum insured | sum insured]] and pay regular or single [[Definition:Premium | premiums]] based on factors including age, health history, smoking status, and the breadth of conditions covered. When a covered diagnosis is confirmed and meets the policy&amp;#039;s clinical definitions, the insurer pays the benefit in full. Policy wordings vary substantially by market and insurer: some contracts cover as few as a dozen conditions, while comprehensive plans in competitive Asian markets may list over a hundred, including early-stage or partial-payment conditions where a fraction of the sum insured is paid for less severe diagnoses. Survival periods — typically 14 to 30 days after diagnosis — are a common feature, and riders such as [[Definition:Waiver of premium | waiver of premium]], multiple-claim provisions, and [[Definition:Return of premium | return of premium]] at expiry further differentiate products. [[Definition:Underwriting | Underwriting]] relies heavily on medical questionnaires and, for larger sums, paramedical examinations, with [[Definition:Actuarial | actuarial]] pricing drawing on epidemiological data and national cancer registries.&lt;br /&gt;
&lt;br /&gt;
💡 The importance of critical illness cover to the insurance industry extends well beyond its premium volume. It sits at the intersection of demographic trends — aging populations, rising cancer survival rates, and growing awareness of cardiovascular disease — that are reshaping [[Definition:Life insurance | life]] and health portfolios worldwide. In the UK, critical illness cover is frequently bundled with [[Definition:Mortgage protection insurance | mortgage protection]] products, while in Hong Kong and Singapore it often serves as the anchor product around which agents build broader financial planning relationships. For insurers, the product presents distinct challenges: medical advances continually blur the line between covered and non-covered conditions, requiring periodic updates to policy definitions and careful [[Definition:Reserving | reserving]]. Regulators in several jurisdictions have pushed for standardized definitions to improve transparency and comparability, and the ongoing evolution of [[Definition:Genomics | genomic]] testing raises questions about future [[Definition:Adverse selection | adverse selection]] dynamics that the industry is actively working to address.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Dread disease insurance]]&lt;br /&gt;
* [[Definition:Life insurance]]&lt;br /&gt;
* [[Definition:Health insurance]]&lt;br /&gt;
* [[Definition:Sum insured]]&lt;br /&gt;
* [[Definition:Adverse selection]]&lt;br /&gt;
* [[Definition:Underwriting]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>